Tacrolimus granules + Tacrolimus granules
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Liver Transplantation
Conditions
Liver Transplantation, Kidney Transplantation
Trial Timeline
Dec 30, 2021 → Mar 14, 2024
NCT ID
NCT05153915About Tacrolimus granules + Tacrolimus granules
Tacrolimus granules + Tacrolimus granules is a approved stage product being developed by Astellas Pharma for Liver Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT05153915. Target conditions include Liver Transplantation, Kidney Transplantation.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05152628 | Approved | Completed |
| NCT05153915 | Approved | Completed |
Competing Products
20 competing products in Liver Transplantation